Cargando…
RASSF1A-Mediated Suppression of Estrogen Receptor Alpha (ERα)-Driven Breast Cancer Cell Growth Depends on the Hippo-Kinases LATS1 and 2
Around 70% of breast cancers express the estrogen receptor alpha (ERα). This receptor is of central importance for breast cancer development and estrogen-dependent tumor growth. However, the molecular mechanisms that are responsible for the control of ERα expression and function in the context of br...
Autores principales: | Roßwag, Sven, Sleeman, Jonathan P., Thaler, Sonja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616147/ https://www.ncbi.nlm.nih.gov/pubmed/34831091 http://dx.doi.org/10.3390/cells10112868 |
Ejemplares similares
-
RASSF1A Suppresses Estrogen-Dependent Breast Cancer Cell Growth through Inhibition of the Yes-Associated Protein 1 (YAP1), Inhibition of the Forkhead Box Protein M1 (FOXM1), and Activation of Forkhead Box Transcription Factor 3A (FOXO3A)
por: Roßwag, Sven, et al.
Publicado: (2020) -
Functional Characterization of Circulating Tumor Cells (CTCs) from Metastatic ER+/HER2− Breast Cancer Reveals Dependence on HER2 and FOXM1 for Endocrine Therapy Resistance and Tumor Cell Survival: Implications for Treatment of ER+/HER2− Breast Cancer
por: Roßwag, Sven, et al.
Publicado: (2021) -
The Drosophila RASSF Homolog Antagonizes the Hippo Pathway
por: Polesello, Cedric, et al.
Publicado: (2006) -
Hippo and rassf1a Pathways: A Growing Affair
por: Fausti, Francesca, et al.
Publicado: (2012) -
Activating Hippo Pathway via Rassf1 by Ursolic Acid Suppresses the Tumorigenesis of Gastric Cancer
por: Kim, Seong-Hun, et al.
Publicado: (2019)